Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIRTIVITY phase 3 study of BI 1291583 in bronchiectasis
CTR20252522Phase 3Active
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of verducatib in bronchiectasis, sponsored by Boehringer Ingelheim. Started Aug 2025; status: active.
02
Drugs
verducatib
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on CTR20252522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252522.